Clinical Trials Directory

Trials / Recruiting

RecruitingNCT05523245

Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI

Status
Recruiting
Phase
Study type
Observational
Enrollment
1,700 (estimated)
Sponsor
Sixth Affiliated Hospital, Sun Yat-sen University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Establish a deep learning model based on multi-parameter magnetic resonance imaging to predict the efficacy of neoadjuvant therapy for locally advanced rectal cancer.This study intends to combine DCE with conventional MRI images for DL, establish a multi-parameter MRI model for predicting the efficacy of CRT, and compare it with the DL and non-artificial quantitative MRI diagnostic model constructed by conventional MRI to evaluate the role of DL in MRI predicting CRT. And this study also tries to build a DL platform to assess the efficacy of LARC neoadjuvant radiotherapy and chemotherapy, accurately assess patients' complete respose (pCR) after CRT, and provide an important basis for guiding clinical decision-making.

Conditions

Timeline

Start date
2022-06-24
Primary completion
2026-12-01
Completion
2027-12-01
First posted
2022-08-31
Last updated
2025-06-04

Locations

4 sites across 1 country: China

Source: ClinicalTrials.gov record NCT05523245. Inclusion in this directory is not an endorsement.

Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Base (NCT05523245) · Clinical Trials Directory